Nektar Therapeutics
NKTR
NKTR
193 hedge funds and large institutions have $121M invested in Nektar Therapeutics in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 56 increasing their positions, 67 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
193
Holders Change
-19
Holders Change %
-8.96%
% of All Funds
3.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
56
Reduced
67
Closed
38
Calls
$465K
Puts
$8K
Net Calls
+$457K
Net Calls Change
+$442K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$2.03M |
| 2 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$1.8M |
| 3 |
D.E. Shaw & Co
New York
|
+$1.53M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.43M |
| 5 |
Two Sigma Advisers
New York
|
+$1.41M |
Top Sellers
| 1 |
ABG
Ally Bridge Group
New York
|
-$3.02M |
| 2 |
Primecap Management
Pasadena,
California
|
-$2.94M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.36M |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
-$1.4M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$1.35M |
